Bausch Lomb (BLCO) Company Overview

Brent Saunders, the CEO of Bausch and Lomb, appears on 'Money Movers' to talk about the changes he has made to the company's portfolio during his leadership. He also shares insights on the growth of Bausch and Lomb and other related topics.

Bausch + Lomb Corporation (NYSE:BLCO) will hold its Q3 2024 Results Conference Call on October 30, 2024, at 8:00 AM ET. The call will feature company representatives, including George Gadkowski, Brenton Saunders, and Osama Eldessouky, along with analysts from various financial institutions. Please be aware that this event is being recorded.

Bausch + Lomb (BLCO) reported quarterly earnings of $0.17 per share, which is higher than the Zacks Consensus Estimate of $0.16 per share. This is a decrease compared to earnings of $0.22 per share from the same period last year.

The day was very busy and full of activities for the company.

This week, the Federal Reserve lowered interest rates by 50 basis points, which led to an increase in stock prices in the technology, construction, industrial, machinery, and financial sectors.

Bausch + Lomb (BLCO) saw an increase in its share price during the last trading session, with higher-than-normal trading volume. However, the recent changes in earnings estimates for the stock do not indicate that this upward trend will continue in the future.

The Financial Times has reported that Bausch + Lomb is discussing the possibility of selling itself with advisors. Previously, the company had tried to separate from its parent company, Bausch Health, through a stock-for-stock transaction.

Bausch + Lomb (BLCO) shares rose on Monday after news emerged that the eyecare company is thinking about selling itself.

Bausch + Lomb (BLCO) reported quarterly earnings of $0.13 per share, matching the Zacks Consensus Estimate. This is a decrease from earnings of $0.18 per share from the same period last year.